Editorial overview: Endocrine and metabolic diseases Druggable diabetes: identification of therapeutic opportunities

Curr Opin Pharmacol. 2018 Dec:43:iii-v. doi: 10.1016/j.coph.2018.10.002. Epub 2018 Nov 13.

Authors

Shanta J Persaud¹, James E Bowe²

Affiliations

¹ Department of Diabetes, School of Life Course Sciences King's College London, London SE1 1UL, UK. Electronic address: shanta.persaud@kcl.ac.uk.
² Department of Diabetes, School of Life Course Sciences King's College London, London SE1 1UL, UK.

PMID: 30446351
DOI: 10.1016/j.coph.2018.10.002

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Biomarkers / blood
Blood Glucose / drug effects*
Blood Glucose / metabolism
Diabetes Mellitus / blood
Diabetes Mellitus / drug therapy*
Diabetes Mellitus / epidemiology
Diabetes Mellitus / physiopathology
Diffusion of Innovation
Drug Design*
Endocrine System / drug effects*
Endocrine System / metabolism
Endocrine System / physiopathology
Humans
Hypoglycemic Agents / adverse effects
Hypoglycemic Agents / therapeutic use*
Molecular Targeted Therapy
Risk Factors

Substances

Biomarkers
Blood Glucose
Hypoglycemic Agents